| Yan, Min |
NCT04682782: Intraoperative Small-dose Esketamine Infusion for Pain Control in Burn Patients |
|
|
| Recruiting | 4 | 26 | RoW | Esketamine, Saline, Placebo | Second Affiliated Hospital, School of Medicine, Zhejiang University | Burns | 12/20 | 12/20 | | |
NCT05035069: Efficacy and Safety of Ciprofol Compared to Propofol for Nonintubated General Anesthesia in Patients Undergoing TAVR |
|
|
| Not yet recruiting | 4 | 24 | RoW | Ciprofol, Propofol | Haisco Pharmaceutical Group Co., Ltd. | Anesthesia, General | 02/22 | 02/22 | | |
NCT04919174: A Randomized Single-blind Clinical Trial of the Efficacy and Safety of Remimazolam in Painless Bronchoscopy |
|
|
| Recruiting | 4 | 364 | RoW | Remimazolam, Remifentanil, Dexmedetomidine | Second Affiliated Hospital, School of Medicine, Zhejiang University | Bronchoscopy, Sedation | 04/22 | 10/22 | | |
NCT04664530: The Study on the Esketamine in the Treatment of Postherpetic Neuralgia |
|
|
| Recruiting | 4 | 48 | RoW | esketamine, Saline | Second Affiliated Hospital, School of Medicine, Zhejiang University | Postherpetic Neuralgia, Esketamine | 06/22 | 12/23 | | |
NCT05881291: Efficacy and Safety of Ciprofol for General Anaesthesia in Patients Undergoing Transcatheter Aortic Valve Replacement |
|
|
| Completed | 4 | 124 | RoW | ciprofol, alfentanil, propofol | Second Affiliated Hospital, School of Medicine, Zhejiang University | Hemodynamics, Transcatheter Aortic Valve Replacement, General Anesthesia, Post-induction Hypotension | 07/24 | 07/24 | | |
RC48-C012, NCT04400695: A Study of RC48-ADC for the Treatment of Locally Advanced or Metastatic Breast Cancer With Low Expression of HER2 |
|
|
| Recruiting | 3 | 366 | RoW | RC48-ADC, RC48, Paclitaxel Injection, Taxol, Docetaxel Injection, Taxotere, Vinorelbine Tartrate Injection, Navelbine, Capecitabine Tablets, Xeloda | RemeGen Co., Ltd. | Breast Cancer | 06/24 | 12/24 | | |
| Active, not recruiting | 3 | 466 | Europe, Canada, Japan, US, RoW | tucatinib, ONT-380, placebo, T-DM1, Kadcyla | Seagen Inc., Seagen Inc., Seattle Genetics, Inc., Seagen Inc | HER2-positive Breast Cancer | 06/23 | 10/27 | | |
|
|
TORCHLIGHT, NCT04085276: Toripalimab in Combination With Nab-Paclitaxel For Patients With Metastatic or Recurrent Triple-Negative Breast Cancer (TNBC) With or Without Systemic Treatment |
|
|
| Active, not recruiting | 3 | 531 | RoW | JS001, Nab-Paclitaxel, Placebo | Shanghai Junshi Bioscience Co., Ltd. | Triple-Negative Breast Cancer | 12/24 | 12/25 | | |
NCT06254742: A Trial of HHPG-19K Injection and Auto-HHPG-19K Injection in Prevention of Chemotherapy-related Moderate to Severe Neutropenia of Patients With Nonmyeloid Malignancies |
|
|
| Not yet recruiting | 3 | 107 | RoW | HHPG-19K Injection | Jiangsu HengRui Medicine Co., Ltd. | Patients With Nonmyeloid Malignancies Receiving Antineoplastic Therapy Based on Chemotherapy Regimens at Moderate to High Febrile Neutropenia (FN) Risk | 05/24 | 06/24 | | |
NCT06419621: PM8002 or Placebo Plus Nab-Paclitaxel as First-line Treatment in Inoperable Locally Advanced/Metastatic Triple-negative Breast Cancer |
|
|
| Recruiting | 3 | 360 | RoW | PM8002, Nab-Paclitaxel, Placebo | Biotheus Inc. | Triple Negative Breast Cancer(TNBC) | 07/27 | 07/28 | | |
TQB2102-III-01, NCT06561607: A Clinical Trial to Evaluate the Efficacy and Safety of TQB2102 for Injection Versus Investigator-Selected Chemotherapy in HER2 Low-Expressing Recurrent/Metastatic Breast Cancer |
|
|
| Not yet recruiting | 3 | 542 | RoW | TQB2102 for Injection, Chemotherapy drug (Capecitabine/Paclitaxel/Albumin Paclitaxel) | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Breast Cancer | 01/27 | 12/28 | | |
| Active, not recruiting | 3 | 654 | Europe, Canada, Japan, US, RoW | Tucatinib, TUKYSA, ONT-380, ARRY-380, Trastuzumab, Herceptin, Herceptin Hylecta, Pertuzumab, Perjeta, Combination product: Trastuzumab + Pertuzumab, Phesgo, Placebo | Seagen Inc., Merck Sharp & Dohme LLC | HER2 Positive Breast Cancer | 05/25 | 10/27 | | |
| Active, not recruiting | 3 | 158 | RoW | Roxadustat, FG-4592, Evrenzo | Second Affiliated Hospital, School of Medicine, Zhejiang University | Perioperative Anemia | 11/26 | 05/27 | | |
| Recruiting | 3 | 314 | RoW | Investigational drug: Recombinant Anti-HER2 Humanized Monoclonal Antibody - Monomethyl Auristatin F Conjugates for Injection (FS-1502), Control drug: Trastuzumab emtansine (Kadcyla, T-DM1) | Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | Breast Cancer | 07/25 | 01/26 | | |
| Active, not recruiting | 2/3 | 549 | Europe, RoW | Oral paclitaxel, Liporaxel®, Paclitaxel injection, Taxol® | Daehwa Pharmaceutical Co., Ltd., Daehwa pharmaceutical Co., Ltd. | Recurrent or Metastatic Breast Cancer | 02/24 | 12/25 | | |
RC48-C006, NCT03500380: A Study of RC48-ADC Administered Intravenously to Patients With HER2-Positive Metastatic Breast Cancer With or Without Liver Metastases |
|
|
| Active, not recruiting | 2/3 | 301 | RoW | RC48-ADC, RC48, Lapatinib, Capecitabine | RemeGen Co., Ltd. | Breast Neoplasms, Breast Diseases, Capecitabine, HER2-positive Breast Cancer, HER2 Positive Breast Carcinoma, HER2-positive Advanced Breast With Liver Metastases | 07/24 | 12/24 | | |
PERMEATE, NCT03691051: A Study of Pyrotinib Plus Capecitabine in Patients With Brain Metastases From HER2-positive Metastatic Breast Cancer |
|
|
| Active, not recruiting | 2 | 78 | RoW | Pyrotinib plus Capecitabine, Irene | Henan Cancer Hospital | HER2 Positive Metastatic Breast Cancer | 04/21 | 12/24 | | |
DAP-Her-01, NCT04293276: Study to Evaluate the Efficacy and Safety of SHR6390 Combined With Pyrotinib in HER2+ Advanced Breast Cancer |
|
|
| Active, not recruiting | 2 | 41 | RoW | Pyrotinib, SHR6390 | Henan Cancer Hospital, Jiangsu HengRui Medicine Co., Ltd. | Metastatic Breast Cancer | 08/21 | 05/23 | | |
NCT04681287: Exploratory Study of Advanced Breast Cancer in HER2 Positive Patients With Failure of Multi-line Therapy Treated by Combination of Inetetamab (Cipterbin) + PD-1 Inhibitor Combined With Utidelone. |
|
|
| Active, not recruiting | 2 | 46 | RoW | inetetamab and PD-1 inhibitor combined with chemotherapy. | Henan Cancer Hospital | HER2 Positive Metastatic Breast Cancer | 11/21 | 12/24 | | |
| Recruiting | 2 | 120 | RoW | TQB3616 capsules, Fulvestrant injection | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | HR-positive, HER2-negative Advanced Breast Cancer | 01/23 | 01/23 | | |
NCT05394285: A Clinical Study of Hetrombopag Olamine Tablets for Thrombocytopenia Induced by Chemotherapy in Advanced Breast Cancer |
|
|
| Recruiting | 2 | 60 | RoW | Hetrombopag, rh-TPO | Henan Cancer Hospital, Jiangsu HengRui Medicine Co., Ltd. | Breast Cancer | 12/24 | 12/24 | | |
NCT06176534: Combination Followed by Maintenance Chemotherapy Versus CDK4/6 Inhibitor Combined With Endocrine Therapy for HR Low/HER2-negative Advanced Breast Cancer: a Prospective, Randomized, Open-label Phase Ⅱ Clinical Trial |
|
|
| Recruiting | 2 | 240 | RoW | Experimental: chemotheyapy, Vinorelbine 25mg/m2，day 1 and day 8 + Capecitabine 2000mg/m2，from day1 to DAY 14, Active Comparator: endocrine therapy | Henan Cancer Hospital | Advanced Breast Cancer, Treatment, HR Low/HER2 Negative | 12/25 | 12/26 | | |
NCT05970432: A Clinical Study of TQH2722 Injection in the Treatment of Moderate to Severe Atopic Dermatitis |
|
|
| Recruiting | 2 | 160 | RoW | TQH2722 injection 300mg-150mg, TQH2722 injection 600mg-300mg, TQH2722 injection 900mg-450mg, TQH2722 injection matching Placebo | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Atopic Dermatitis | 03/24 | 03/24 | | |
NCT05336721: A Phase II Study of Chiauranib in Combine With Capecitabine in TNBC |
|
|
| Terminated | 2 | 9 | RoW | Chiauranib, capecitabine | Chipscreen Biosciences, Ltd. | Triple-negative Breast Cancer | 10/24 | 11/24 | | |
| Recruiting | 2 | 100 | RoW | utidelone, Bevacizumab | Henan Cancer Hospital | Breast Cancer | 05/24 | 05/24 | | |
NCT05328440: Treatment of Dalpiciclib Combined With Pyrotinib for Trastuzumab-sensitive HER2+ Advanced Breast Cancer(DAP-Her-02) |
|
|
| Recruiting | 2 | 120 | RoW | Pyrotinib Maleate, Pyrotinib, Dalpiciclib Isethionate Tablets, SHR6390, Inetetamab, Fulvestrant | Henan Cancer Hospital, Jiangsu HengRui Medicine Co., Ltd. | Breast Neoplasms | 06/24 | 01/26 | | |
NCT06458413: Utidelone Capsule Plus Capecitabine (CAP) for Metastatic Breast Cancer |
|
|
| Recruiting | 2 | 40 | RoW | Utidelone Capsule Plus Capecitabine | Min Yan, MD, Beijing Biostar Pharmaceuticals Co., Ltd. | Breast Cancer Recurrent | 06/25 | 12/25 | | |
HNCH-MBC15-BM06, NCT06598046: A Single-arm, Prospective Phase Ⅱ Clinical Study of Utidelone Combined with Capecitabine in the Treatment of Active Brain Metastasis of TNBC |
|
|
| Recruiting | 2 | 48 | RoW | Utidelone and capecitabine | Henan Cancer Hospital | Metastatic Breast Cancer | 06/26 | 08/26 | | |
NCT05296577: Anlotinib Combination With Vinorelbine in the HER2- Advanced Breast Cancer |
|
|
| Recruiting | 2 | 134 | RoW | anlotinib and vinorelbine, AL3818 and vinorelbine, Vinorelbine injection, vinorelbine | Henan Cancer Hospital | Breast Cancer | 09/24 | 12/24 | | |
NCT05769010: Study of SHR-A1811 in HER2-expression Advanced Breast Cancer with Brain Metastases |
|
|
| Recruiting | 2 | 125 | RoW | SHR-A1811, Pyrotinib, Bevacizumab | Henan Cancer Hospital | Metastatic Breast Cancer | 10/25 | 04/26 | | |
NCT05872347: Efficacy and Safety of SPH4336 in Combination With Endocrine Therapy in Breast Cancer Patients With Brain Metastases. |
|
|
| Recruiting | 2 | 52 | RoW | SPH4336 Tablets | Shanghai Pharmaceuticals Holding Co., Ltd | Breast Cancer Brain Metastases | 12/25 | 12/25 | | |
NCT06208410: A Clinical Study of JS105 in Combination With Other Anti-tumor Therapies in Patients With Solid Tumors |
|
|
| Recruiting | 1/2 | 306 | RoW | JS105, Fulvestrant injection, Dalpiciclib Isetionate Tablets, Toripalimab Injection, Paclitaxel for Injection (Albumin Bound), Fluzoparib Capsules, Pyrotinib Maleate Tablets, Capecitabine Tablets | Risen (Suzhou) Pharma Tech Co., Ltd. | Advanced Solid Tumors | 02/26 | 02/26 | | |
NCT06464055: A Study of GQ1010 in Subjects With Advanced Solid Tumors |
|
|
| Recruiting | 1/2 | 220 | RoW | Dose Escalation, Dose Expansion1, Dose Expansion2, phase II | GeneQuantum Healthcare (Suzhou) Co., Ltd. | Advanced Malignant Solid Tumors | 05/28 | 12/28 | | |
NCT05176080: Famitinib Plus SHR6390 and Endocrine Therapy in the Treatment of HR-positive, HER2-negative Advanced Breast Cancer |
|
|
| Terminated | 1/2 | 46 | RoW | Famitinib, SHR6390, Dalpiciclib, Fulvestrant | Henan Cancer Hospital | Metastatic Breast Cancer | 07/24 | 07/24 | | |
KL264-01, NCT04152499: Phase I-II, FIH, TROP2 ADC, Advanced Unresectable/Metastatic Solid Tumors, Refractory to Standard Therapies |
|
|
| Recruiting | 1/2 | 1300 | Canada, US, RoW | SKB264 | Klus Pharma Inc. | Epithelial Ovarian Cancer, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Urothelial Carcinoma, Non-Small Cell Lung Cancer, Small-Cell Lung Cancer, Endometrial Carcinoma, Head and Neck Squamous Cell Carcinoma, Breast Cancer | 08/25 | 07/26 | | |
NCT06679036: A Trial of HRS-2189 in Combination With Fluvastatin±HRS-6209, or HRS-8080±HRS-6209, or HRS-6209+HRS-1358 in Breast Cancer Patients |
|
|
| Not yet recruiting | 1/2 | 300 | RoW | HRS-2189, Fluvustat, HRS-8080, HRS-6209, HRS-1358 | Shandong Suncadia Medicine Co., Ltd. | Advanced Unresectable or Metastatic Breast Cancer | 10/26 | 12/26 | | |
NCT05335473: Iribrine Plus Tucidinostat in the Treatment of HR+/HER2 Advanced Breast Cancer After CDK4/6 Inhibitor Failure |
|
|
| Recruiting | 1/2 | 87 | RoW | Eribulin and Tucidinostat | Henan Cancer Hospital | HR Positive HER2 Negative Advanced Breast Cancer | 05/25 | 11/25 | | |
NCT05438329: First-in-human Study of DB-1305/BNT325 for Advanced/Metastatic Solid Tumors |
|
|
| Recruiting | 1/2 | 902 | US, RoW | DB-1305/BNT325, DB-1305/BNT325 for Injection, Pembrolizumab, BNT327 | DualityBio Inc., BioNTech SE | Advanced Solid Tumor | 06/25 | 06/25 | | |
| Recruiting | 1 | 70 | RoW | TQB3915 tablets | Chia Tai Tianqing Pharmaceutical Group Co., Ltd. | Advanced Malignant Tumor | 06/23 | 06/24 | | |
NCT05245058: SPH5030 Tablets in Subjects With Advanced Her2-positive Solid Tumors |
|
|
| Recruiting | 1 | 150 | RoW | SPH5030 tablets | Shanghai Pharmaceuticals Holding Co., Ltd | HER2-positive Advanced Solid Tumors | 12/24 | 12/24 | | |
NCT05414136: Evaluating the Safety, Tolerability, and Pharmacokinetics of BAT1006 |
|
|
| Completed | 1 | 37 | RoW | BAT1006, Recombinant humanized anti-HER2 monoclonal antibody for injection | Bio-Thera Solutions | Advanced Solid Tumor | 06/24 | 06/24 | | |
NCT05473624: Study of HRS-1167 as Monotherapy in Patients With Advanced Solid Tumors |
|
|
| Recruiting | 1 | 153 | RoW | HRS-1167 | Jiangsu HengRui Medicine Co., Ltd. | Advanced Solid Tumors | 12/24 | 12/24 | | |
CGCT-01, NCT02130752: Ultrasonic Scalpel vs. Monopolar Electrocautery for D2 Distal Gastric Carcinoma Surgery |
|
|
| Recruiting | N/A | 430 | RoW | Monopolar electrocautery, Ultrasonic scalpel | West China Hospital | Gastric Cancer, Surgery, Ultrasonic Scalpel, Monopolar Electrocautery, Operation Time, Blood Loss, Surgical, Quality of Life, External Causes of Morbidity and Mortality | 10/19 | 10/22 | | |
NCT04613869: The Effect of Esketamine on Patients Undergoing Tumor Surgery |
|
|
| Active, not recruiting | N/A | 282 | RoW | High-dose Esketamine hydrochloride+Hydromorphone, Low-dose Esketamine hydrochloride+Hydromorphone, Hydromorphone | Second Affiliated Hospital, School of Medicine, Zhejiang University | Tumor Surgery | 08/21 | 10/21 | | |
NCT04860648: Lung Ultrasound Guided Prevention of Postoperative Pulmonary Complications in Moderate to High Risk Patients |
|
|
| Not yet recruiting | N/A | 592 | RoW | lung ultrasound, doctors' clinical decision | Second Affiliated Hospital, School of Medicine, Zhejiang University | Postoperative Respiratory Complication | 12/21 | 03/22 | | |
NCT05267145: The Protection of ACD III on Erythrocytes in Intraoperative Blood Salvage During Cardiopulmonary Bypass |
|
|
| Not yet recruiting | N/A | 60 | RoW | blood preservation solution III | Second Affiliated Hospital, School of Medicine, Zhejiang University | Red Blood Cell Disorder | 06/22 | 08/22 | | |
NCT04934657: Association of Perioperative Daily Steps and Postoperative Recovery Among Surgical Patients |
|
|
| Recruiting | N/A | 487 | RoW | no intervention | Second Affiliated Hospital, School of Medicine, Zhejiang University | Postoperative Recovery | 08/22 | 12/22 | | |
NCT05130333: The Clinical Research of Needle Electrodes Used in Bispectral Index to Monitor the Depth of Anesthesia |
|
|
| Not yet recruiting | N/A | 120 | RoW | No intervention | Second Affiliated Hospital, School of Medicine, Zhejiang University | Intraoperative Monitoring, Depth of Anesthesia | 10/22 | 02/23 | | |
NCT05338554: Optimize the Effects of Repetitive Transcranial Magnetic Stimulation on Neuropathic Pain |
|
|
| Completed | N/A | 40 | RoW | Repetitive transcranial magnetic stimulation | Second Affiliated Hospital, School of Medicine, Zhejiang University | Neuropathic Pain, Repetitive Transcranial Magnetic Stimulation | 12/22 | 12/22 | | |
NCT05360030: Mechanism of Analgesic Effect on Prolonged Continuous Theta Burst Stimulation |
|
|
| Completed | N/A | 45 | RoW | Naloxone, Saline, Ketamine Hydrochloride, pcTBS of M1, pcTBS of DLPFC, SHAM stimulation | Second Affiliated Hospital, School of Medicine, Zhejiang University | Chronic Pain, rTMS | 12/22 | 12/22 | | |
NCT05168319: Effects and Mechanism of Prolonged Continuous Theta Burst Stimulation on Neuropathic Pain |
|
|
| Completed | N/A | 94 | RoW | Repetitive transcranial magnetic stimulation, Sham stimulation | Second Affiliated Hospital, School of Medicine, Zhejiang University | Neuropathic Pain, Repetitive Transcranial Magnetic Stimulation | 12/22 | 01/23 | | |
NCT05706441: Lung and Diaphragm Ultrasound Evaluation During Weaning From Mechanical Ventilation in COVID-19 Patients |
|
|
| Completed | N/A | 35 | RoW | Point-of-Care Ultrasound | Second Affiliated Hospital, School of Medicine, Zhejiang University | Weaning, COVID-19, Lung Ultrasound, Diaphragm Ultrasound | 03/23 | 03/23 | | |
| Recruiting | N/A | 1250 | RoW | EEG(Electroencephalogram) change | Air Force Military Medical University, China | Aging, Postoperative Cognitive Dysfunction, EEG With Periodic Abnormalities | 03/23 | 04/23 | | |
NCT05713305: Effect of an Online Self-help Psychological Intervention on Non-ICU Specialty Care During the COVID-19 Outbreak |
|
|
| Completed | N/A | 110 | RoW | Online-based self-help psychological intervention, Provide online mental health knowledge | Second Affiliated Hospital, School of Medicine, Zhejiang University | SARS-CoV-2 Infection, Staff Attitude, Anxiety, Mental Health Issue | 06/23 | 06/23 | | |
NCT05637164: Determination of the ED50 and ED95 of Prophylactic Norepinephrine Infusion for Preventing Post-induction Hypotension in Elderly Patients Undergoing Major Abdominal Surgery |
|
|
| Recruiting | N/A | 40 | RoW | norepinephrine bitartrate | Second Affiliated Hospital, School of Medicine, Zhejiang University | Norepinephrine, Post-induction Hypotension | 05/23 | 05/23 | | |
NCT05871203: Changes in Gene Expression and Prognosis of Blood Immune Cells After Cardiopulmonary Bypass Surgery |
|
|
| Recruiting | N/A | 12 | RoW | Gene sequencing | Second Affiliated Hospital, School of Medicine, Zhejiang University | Acute Kidney Injury | 06/23 | 07/23 | | |
NCT04879602: Effect of Suctioning by Bronchoscope on Postoperative Pulmonary Complications Among Patients With SCI in the PACU |
|
|
| Recruiting | N/A | 24 | RoW | suction with bronchoscopy | Second Affiliated Hospital, School of Medicine, Zhejiang University | Spinal Cord Injuries | 12/23 | 12/23 | | |
NCT05852067: Effects of Prolonged Continuous Theta Burst Stimulation on Pain and Neural Excitability |
|
|
| Not yet recruiting | N/A | 25 | RoW | pcTBS of M1, SHAM stimulation | Second Affiliated Hospital, School of Medicine, Zhejiang University | pcTBS, Pain | 12/23 | 07/24 | | |
NCT05689216: Timed Awake Prone and Repositioning for Patients With Covid-19-induced Hypoxic Respiratory Failure. |
|
|
| Not yet recruiting | N/A | 286 | RoW | Awake timed prone and repositioning | Second Affiliated Hospital, School of Medicine, Zhejiang University | Corona Virus Infection, Hypoxic Respiratory Failure | 02/24 | 02/24 | | |
NCT05749328: Effect of Preoperative Oral Carbohydrate on Hypotension After Anesthesia Induction in Elderly Patients With Joint Replacement |
|
|
| Not yet recruiting | N/A | 210 | NA | Carbohydrate | Second Affiliated Hospital, School of Medicine, Zhejiang University | Carbohydrates, Aged, Post-induction Hypotension | 03/24 | 06/24 | | |
NCT05359120: Pyrotinib Combined With Capecitabine in HER-2 Positive Advanced Breast Cancer and Brain Metastases (Post-PERMEATE) |
|
|
| Recruiting | N/A | 300 | RoW | | Henan Cancer Hospital | Breast Cancer | 05/24 | 05/24 | | |
NCT05353348: Effect of the Combined Programme on Perioperative Anaemia（CPPA） |
|
|
| Recruiting | N/A | 110 | RoW | Iron Sucrose, recombinant human erythropoietin, ascorbic acid, conventional treatment | Second Affiliated Hospital, School of Medicine, Zhejiang University | Patient Blood Management, Cardiac Surgery, Iron Deficiency Anemia | 04/25 | 04/25 | | |
NCT06459141: The Effect of Hemodilution on Intraoperative Allogeneic Transfusion (HEAL) |
|
|
| Recruiting | N/A | 150 | RoW | acute normovolemic hemodilution | Second Affiliated Hospital, School of Medicine, Zhejiang University | Acute Normovolemic Hemodilution, Bone Tumor, Goal-Directed Fluid Therapy, Transfusion | 05/26 | 05/26 | | |
NCT06603350: The Effect of Perioperative Factors on Postoperative Outcomes After Lung Transplantation |
|
|
| Recruiting | N/A | 200 | RoW | No intenvention | Second Affiliated Hospital, School of Medicine, Zhejiang University | Postoperative Complications After Lung Transplantation | 02/26 | 08/26 | | |
CIPAT, NCT06012760: The Effect of Combined Iron Protocols on Perioperative Allogeneic Transfusion |
|
|
| Recruiting | N/A | 400 | RoW | Iron sucrose, Human Erythropoietin Injection, Vitamin C, Standard Medical Care | Second Affiliated Hospital, School of Medicine, Zhejiang University, First Affiliated Hospital of Wenzhou Medical University, Taizhou Hospital of Zhejiang Province affiliated to Wenzhou Medical University, The Central Hospital of Lishui City | Anemia, Iron Deficiency Anemia, Perioperative, Transfusion, Cardiac Surgery | 01/26 | 03/26 | | |
NCT04980742: Perioperative Risk Factors of Outcomes for Cardiac Surgery: A Retrospective Study |
|
|
| Recruiting | N/A | 3000 | RoW | acute normovolemic hemodilution | Second Affiliated Hospital, School of Medicine, Zhejiang University | Post-cardiac Surgery, Blood Transfusion Complication, Prognosis | 12/21 | 12/21 | | |
NCT04520919: Feasibility Study of a Hemodynamic Parameter Algorithm |
|
|
| Recruiting | N/A | 139 | RoW | anesthesia;Radial artery puncture | Second Affiliated Hospital, School of Medicine, Zhejiang University | Anesthesia | 06/22 | 06/22 | | |
NCT05078086: Study on the Relationship of Arterial-venous Oxygen Difference and Postoperative Complications After Cardiac Surgery. |
|
|
| Completed | N/A | 314 | RoW | No intervention | Second Affiliated Hospital, School of Medicine, Zhejiang University | Patient Blood Management, Cardiac Surgery, Transfusion | 05/23 | 05/23 | | |
| Zhang, Fengjiang |
NCT05961358: Auxiliary Anesthesia Technique for Extracting Advanced Hemodynamic Parameters Based on Peripheral Arterial Waveform Photography |
|
|
| Recruiting | N/A | 150 | RoW | snapshots or videos of monitor, Pressure transducer | Second Affiliated Hospital, School of Medicine, Zhejiang University | Anesthesia | 08/24 | 08/24 | | |
NCT06374953: A Novel Viscoelastic Test Based on Ultrasonic Guided Wave for Identifying Hyperfibrinolysis Rapidly |
|
|
| Recruiting | N/A | 140 | RoW | Ultrasound-based viscoelastic hemostasis analysis | Second Affiliated Hospital, School of Medicine, Zhejiang University | Hyperfibrinolysis | 09/24 | 09/24 | | |
NCT06434389: A Point-of-care Electrochemical-based Device for Rapid Detection of Fibrinogen on Type A Aortic Dissection Surgery |
|
|
| Not yet recruiting | N/A | 150 | RoW | the Electrochemical-based device | Second Affiliated Hospital, School of Medicine, Zhejiang University | Hypofibrinogenemia | 08/24 | 11/24 | | |
NCT05921799: A Novel Point-to-care Method for Fast Evaluation of Viscoelastic Hemostasis Analysis |
|
|
| Recruiting | N/A | 200 | RoW | Blood specimen collection | Second Affiliated Hospital, School of Medicine, Zhejiang University | Perioperative Period | 06/24 | 06/24 | | |
